Tryptophan hydroxylase gene polymorphism and 5HT transporter gene promoter region polymorphism in anxiety and depressive disorder-comprehensive literature review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242971Keywords:
5-HTTLPR (serotonin-transporter-linked promoter region), Tryptophan hydroxylase (TPH), Anxiety and depressive disordersAbstract
Anxiety and depressive disorders are multifactorial conditions influenced by genetic and environmental factors. Research has highlighted the role of genetic polymorphisms, particularly in the tryptophan hydroxylase (TPH) and serotonin transporter or 5-HTT (5-hydroxy tryptamine transporter), which regulate serotonin, a key neurotransmitter in mood regulation. Polymorphisms in TPH1 and TPH2, enzymes involved in serotonin biosynthesis, have been linked to depression and anxiety, though findings are inconsistent. While certain TPH1 polymorphisms, like T27224C, may offer protection, TPH2 variants, such as rs1386494, have been associated with major depression in specific populations. The 5-HTTLPR (serotonin-transporter-linked promoter region shows varying associations with anxiety and depressive disorders. The short (S) allele of 5-is associated with reduced serotonin uptake, higher neuroticism, and increased risk for anxiety and depression, particularly when combined with stressful life events. However, gene-environment interactions and population differences complicate these associations, as treatment responses vary across different genotypes. Despite the inconclusive results, these studies underscore the importance of serotonergic genes in mood disorders, emphasizing the need for further research into genetic, environmental, and psychological interactions to improve understanding and treatment of anxiety and depressive disorders.
References
Rihmer Z, Angst A. Mood Disorders: Epidemiology in. Comprehensive textbook of Psychiatry, Baltimore. Lipincott Williams and Wilkins. 2004. Avialable at: https://www.researchgate.net.
Kendler KS. Major Depression and generalised anxiety disorder same genes partly different environments. Brit J Psychiatry. 1996;168:68-75.
Sun S, Tsai HW, Ko HC. Association of TPH gene polymorphism with depression and anxiety, Genes Brain and Behaviour. 2004;3:328-36.
Himmelhoch J, Levine J, Gershon S. Historical overview of the relationship between anxiety disorders and affective disorders. Depression Anx. 2001;14:53-66.
Asperg M,TraskmanL,Thoren P:5 HIAA in the CSF, a biochemical suicidal predictor. Arch Gen Psychiatry. 1976;33:1193-7.
Zill TC, Baghai P, Wanger Z. SNP haplotype analysis of TPH2 gene provide evidence for association with major depression. Molecular psych. 2004;9:1030-6.
Walther DJ, Peter JU, Basammakh S. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
Song YJ, Yu HS, Binglai S. Serotonin transporter and tryptophan hydroxylase gene polymorphism in Chinese patients with GAD. Psych Gen. 2005;15:7-11.
Mossner R, Frietag CM, Gutknecht L. The novel brain specific tryptophan hydroxylase 2 in panic disorder. J Psychopharmacol. 2004;20:547-52.
Ari I, Eija SS, Merza V. 5HTR1A,5HTR2A,5HTR6, TPH1 and TPH2 polymorphisms and major depression,Genetics of Nerv Syst Disease. 2009;20:1125-8.
L Gutknecht, C Jacob, A Strobal. Tryptophan hydroxylase- 2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J of Neuropsychopharmacol. 2007;10:309-20.
Herman MJ, Hater T, Mullen F:Additive effects of serotonin transporter and TPH2 gene variation on emotional processing, Cereb Cortex 2007;17:1160-3.
Gizatullen R, Zabouli G, Johnson EG. Tryptophan hydroxylase 2 gene unlike tryptophan 1 exhibits no association with stress induced depression, J Affective Disorders. 2008;107:175-9.
Canli T, Congdon, Gutknecht EL. Amygdala responsiveness is modulated by TPH2 gene variation, J Neural Transmission 2005;112:1479-85.
Mushtaq R. Tryptophan hydroxylase 2 gene polymorphism in anxiety and depressive disorder in kashmiri population. J Clin Diag Res. 2014;8(6):1-3.
Mushtaq R, Tarfarosh SF, Dar MM, Hussain A, Shoib S, Shah T, Shah S, Manzoor M. Is there a link between depressive disorders and tryptophan Hydroxylase 1 (TPH1) Gene Polymorphism?. Study from a Distressed Area, Kashmir (India). Cureus. 2016;8(7):673.
Tao T, Chattun MR, Ywan R. TPH-2 Gene polymorphism in major depressive disorder patients with early-wakening symptom. Neurosci. 2018;15:7-11.
Caspi A. Influence of life stress on depression: Moderation by a polymorphism in the 5 HTT gene. Science: 2003;301:386-9.
Hariri AR, Maltay VS, Tessitore A, Kolacharan B, Fera F, Goldmen Egan MF, Weinberger D. R:Serotonin transporter genetic variations and the response of the human amygdala. Science 2002:297:400-4.
Kenneth S, Kendler ER, Carol A. The structure of genetic and environmental risk factors for common psychiatric and substance abuse disorders in men and women, Arch Gen Psych. 2003:60:929-37.
Kilpatricik GD, Koeonen CK, Ruggiero KJ, Acierno R, Galea S, Resnick SR, et al. The serotonin transporter genotype social support and moderation of PTSD and depression in hurricane exposed adults. Am J Psychiatry. 2007:164(11):1693-9.
Margoob MA, Mushtaq D, Murtza I. Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor in depression. Ind J Psych. 2008:50(1):47-50.
DF Levinson. The genetics of depression- a review. Biol Psychiatry. 2006;60:84-92.
G Zalsman, YY Huang, MA Oquindo. Association of 5HTTLPR with stress life events and severity of depression. Am J Psychiatry. 2006;163:1588-93.
Tebriwal P, Kiran kumar HB, Shubha GN. Association of serotonin transporter gene polymorphisms with obsessive compulsive disorder. Ind J Med Research. 2010;132:690-5.
Margoob MA, Mushtaq D, Murtza I:Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor in depression. Ind J Psych. 2008:50(1):47-50.
Mushtaq R, Shoib S, Shah T, Mushtaq S. Tryptophan hydroxylase 2 gene polymorphismin anxiety and depressive disorder in kashmiri population. J Clin Diagn Res. 2014;8(6):1-3.
Miozzo R, Eaton WW, Joseph Bienvenu O 3rd, Samuels J, Nestadt G. The serotonin transporter gene polymorphism (SLC6A4) and risk for psychiatric morbidity and comorbidity in the Baltimore ECA follow-up study. Compr Psychiatry. 2020;102:152199.
Simonyte S, Grabauskyte I, Macijauskiene J, Lesauskaite V, Lesauskaite V, Kvaal KS, Stewart R. Associations of the serotonin transporter gene polymorphism, 5-HTTLPR, and adverse life events with late life depression in the elderly Lithuanian population. Sci Rep. 2023;4:6-9.
N A Gillespie, J B Whitfield, B Williams. The relationship between stressful life events, the serotonin transporter genotype and major depression.Psychol Med. 2005;35:101-11.
L Mandelli, A Serretti, E Marino. Interaction between 5HTT, COMT, and stressful life events in mood disorders. Int J neuropsychopharmacol. 2007;10:437-47.
Eley TC, Sugden K, Corsico A. Gene environment interaction analysis of serotonin system markers with adolescent depression. Molecular psychiatry. 2004:1-8.
J Belsky. Pluess: Beyond stress diathesis- Differential susceptibility to environmental influences. Psychological Bulletin. 2009;135:885-908.
A Neumeister, A Konstantinidis, J Statsney et al:Association between 5HTTLPR and behavioural response to tryptophan deprivation in healthy women. Arch Gen Psychiatry. 2002;59:613-20.
J Waider, N Araragi, L Gutknecht , KP Lesch. TPH2 in disorders of cognitive control and emotional regulation- a perspective. Psychoneuroendo. 2011;36: 393-405.
Heils A, Teufel A, Petri S, Riederer P,Bengel D et al:Allelic variations of human serotonin transporter gene expression. Neuro chem. 1996:66:1-4
Rama MS, Bauman AL, Moore KR. Antidepressants and cocaine sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Procedures of the National Academy of Science. USA:1993:90:2542-6.
A Caspi, AR Hariri, A Holmes. Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010;167:509-27.
